These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Comparison of clinical characteristics of extraovarian peritoneal serous papillary carcinoma with papillary serous ovarian carcinoma]. Peng YZ; Shen K; Wu M; Huang HF; Pan LY; Yang JX; Lang JH Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):243-5. PubMed ID: 15924670 [TBL] [Abstract][Full Text] [Related]
6. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Ayhan A; Taskiran C; Yigit-Celik N; Bozdag G; Gultekin M; Usubutun A; Guler N; Yuce K Int J Gynecol Cancer; 2006; 16(2):484-9. PubMed ID: 16681715 [TBL] [Abstract][Full Text] [Related]
7. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma. Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644 [TBL] [Abstract][Full Text] [Related]
8. [Extraovarian peritoneal serous papillary carcinoma: an unusual surgical case]. Meier C; Seifert M; Wehrli H Swiss Surg; 1999; 5(1):14-7. PubMed ID: 10073126 [TBL] [Abstract][Full Text] [Related]
9. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Ben-Baruch G; Sivan E; Moran O; Rizel S; Menczer J; Seidman DS Gynecol Oncol; 1996 Mar; 60(3):393-6. PubMed ID: 8774644 [TBL] [Abstract][Full Text] [Related]
10. [Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer]. Yan X; An N; Jiang GQ; Gao M; Gao YN Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):298-301. PubMed ID: 18788637 [TBL] [Abstract][Full Text] [Related]
11. [Extraovarian peritoneal serous papillary carcinoma: studies of clinical and pathological features]. Shi X; Guo Y; Li J Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):711-3. PubMed ID: 9387509 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer. Gordon AN; Asmar L; Messing MJ; Street DG; Pippitt CH; Bailey CL; Savage J; Young JA Gynecol Oncol; 2004 Aug; 94(2):533-9. PubMed ID: 15297200 [TBL] [Abstract][Full Text] [Related]
13. [Extraovarian peritoneal serous papillary carcinoma: a clinicopathologic analysis of 11 cases]. Zhang G; Jiang S; Wang B Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):707-10. PubMed ID: 9387508 [TBL] [Abstract][Full Text] [Related]
14. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Kennedy AW; Hart WR Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004 [TBL] [Abstract][Full Text] [Related]
15. [Normal-sized ovary carcinoma syndrome--clinical and pathological analysis of 11 cases]. Yao Z; Li L; Yang H Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):383-6. PubMed ID: 10921039 [TBL] [Abstract][Full Text] [Related]
17. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A; Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209 [TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women]. Tang L; Zheng M; Xiong Y; Ding H; Liu FY Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034 [TBL] [Abstract][Full Text] [Related]
19. The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer. Barlow TS; Przybylski M; Schilder JM; Moore DH; Look KY Int J Gynecol Cancer; 2006; 16(2):496-500. PubMed ID: 16681717 [TBL] [Abstract][Full Text] [Related]
20. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Gershenson DM; Sun CC; Lu KH; Coleman RL; Sood AK; Malpica A; Deavers MT; Silva EG; Bodurka DC Obstet Gynecol; 2006 Aug; 108(2):361-8. PubMed ID: 16880307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]